Literature DB >> 26266779

[The biological functions and regulations of competing endogenous RNA].

Jing-qiu Li1, Jie Yang1, Ping Zhou1, Yan-ping Le1, Zhao-hui Gong1.   

Abstract

Recent studies demonstrate that RNA species could regulate each other by competing for shared microRNA response elements (MREs). This regulatory model is called competing endogenous RNA (ceRNA). Currently, the identified ceRNAs cover coding and non-coding RNAs. The latter includes pseudogene transcripts, long non-coding RNAs (lncRNAs), circular RNAs (circRNAs) and so on. In this review, we summarize the biological functions of regulatory networks consisting of various types of ceRNAs and their roles in the pathological and physiological processes. Additionally, several factors that may regulate ceRNAs were discussed.

Mesh:

Substances:

Year:  2015        PMID: 26266779     DOI: 10.16288/j.yczz.15-073

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  5 in total

1.  Down-regulated Circ_0000190 promotes cervical cancer by facilitating the activity of proto-oncogene protein EIF4E.

Authors:  Chengcheng Yang; Jia Xie; Qian Chen; Yisi Yang
Journal:  Cell Cycle       Date:  2022-04-13       Impact factor: 5.173

Review 2.  Circular RNAs in Cardiovascular Disease: An Overview.

Authors:  Ximin Fan; Xinyu Weng; Yifan Zhao; Wei Chen; Tianyi Gan; Dachun Xu
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

Review 3.  Emerging roles of circRNA in formation and progression of cancer.

Authors:  Yuting Yin; Jiali Long; Qinglian He; Yuling Li; Yanqiu Liao; Peishan He; Wei Zhu
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

4.  Circular RNA hsa_circ_0001649 inhibits hepatocellular carcinoma progression via multiple miRNAs sponge.

Authors:  Yang Su; Chao Xu; Yuting Liu; Yilin Hu; Haiyan Wu
Journal:  Aging (Albany NY)       Date:  2019-05-28       Impact factor: 5.682

5.  Long Noncoding RNA PVT1 Promotes Melanoma Progression via Endogenous Sponging miR-26b.

Authors:  Bao-Juan Wang; Hong-Wei Ding; Guo-An Ma
Journal:  Oncol Res       Date:  2017-04-12       Impact factor: 5.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.